Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Novartis has received FDA approval for its new molecular entity, Zykadia (ceritinib), for treating patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).   Zykadia is an oral anaplastic lymphoma kinase...

Bristol-Myers Squibb Company has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological...

Pfizer Inc. confirmed on April 28, 2014 of its interest in a possible merger transaction with AstraZeneca despite AstraZeneca's assertion that it wishes to remain an independent company. Pfizer Chairman and CEO Ian Read outlined...

Actavis plc has entered into an agreement with Pfizer, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Celebrex® (celecoxib) 50-mg, 100-mg, 200-mg and 400-mg capsules. Celebrex® is indicated for the...

FDA has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). Sylvant is marketed by Janssen Biotech Inc., based in Horsham,...